Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,278 | 255 | 92.0% |
| Education | $371.90 | 4 | 8.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $498.12 | 30 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $357.49 | 14 | $0 (2023) |
| Amgen Inc. | $314.24 | 15 | $0 (2023) |
| SEAGEN INC. | $275.23 | 10 | $0 (2024) |
| Janssen Biotech, Inc. | $249.99 | 23 | $0 (2024) |
| Merck Sharp & Dohme LLC | $237.13 | 13 | $0 (2024) |
| PFIZER INC. | $233.72 | 14 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $217.22 | 16 | $0 (2022) |
| Incyte Corporation | $177.89 | 7 | $0 (2024) |
| Karyopharm Therapeutics Inc. | $155.82 | 8 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $509.69 | 17 | ABBVIE INC. ($144.16) |
| 2023 | $380.39 | 13 | AstraZeneca Pharmaceuticals LP ($119.50) |
| 2022 | $1,402 | 79 | Novartis Pharmaceuticals Corporation ($187.89) |
| 2021 | $2,358 | 150 | Novartis Pharmaceuticals Corporation ($262.00) |
All Payment Transactions
259 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $31.29 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | Novocure Inc. | Optune Lua (NovoTTF-200T) (Device) | Food and Beverage | Cash or cash equivalent | $15.60 | General |
| Category: Oncology | ||||||
| 11/12/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: ONCOLOGY | ||||||
| 11/05/2024 | SEAGEN INC. | — | Education | In-kind items and services | $95.00 | General |
| 10/30/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY, DARZALEX | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Oncology | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: ONCOLOGY | ||||||
| 09/12/2024 | PFIZER INC. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Oncology | ||||||
| 08/01/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: ONCOLOGY | ||||||
| 07/26/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Education | In-kind items and services | $95.00 | General |
| Category: ONCOLOGY | ||||||
| 07/09/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: ONCOLOGY | ||||||
| 07/09/2024 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 04/23/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $25.39 | General |
| Category: Hematology/Oncology | ||||||
| 04/11/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Oncology | ||||||
| 11/17/2023 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $119.50 | General |
| Category: Oncology | ||||||
| 11/07/2023 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: Oncology | ||||||
| 10/03/2023 | Janssen Biotech, Inc. | TECVAYLI (Biological) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Oncology | ||||||
| 09/21/2023 | PFIZER INC. | INLYTA (Drug), XTANDI, TALZENNA | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: ONCOLOGY | ||||||
| 08/08/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: ONCOLOGY | ||||||
| 07/28/2023 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Oncology | ||||||
| 07/27/2023 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 06/29/2023 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $22.46 | General |
| Category: Hematology/Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 295 | 354 | $86,886 | $21,481 |
| 2022 | 2 | 43 | 47 | $11,642 | $3,409 |
| 2020 | 1 | 14 | 14 | $126.00 | $43.78 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 82 | 100 | $21,400 | $5,912 | 27.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 43 | 49 | $15,190 | $4,549 | 29.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 56 | 88 | $13,024 | $3,752 | 28.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 64 | 67 | $18,023 | $2,549 | 14.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 22 | $8,206 | $2,163 | 26.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 17 | 17 | $7,820 | $1,822 | 23.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 11 | 11 | $3,223 | $734.00 | 22.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 34 | $9,146 | $2,687 | 29.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 13 | $2,496 | $722.21 | 28.9% |
| 81001 | Manual urinalysis test with examination using microscope | Office | 2020 | 14 | 14 | $126.00 | $43.78 | 34.7% |
About Melissa Bogle, FNP-BC
Melissa Bogle, FNP-BC is a Nurse Practitioner healthcare provider based in Princeton, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2018. The National Provider Identifier (NPI) number assigned to this provider is 1972097103.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Melissa Bogle, FNP-BC has received a total of $4,650 in payments from pharmaceutical and medical device companies, with $509.69 received in 2024. These payments were reported across 259 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($4,278).
As a Medicare-enrolled provider, Bogle has provided services to 352 Medicare beneficiaries, totaling 415 services with total Medicare billing of $24,934. Data is available for 3 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Princeton, WV
- Active Since 06/20/2018
- Last Updated 06/20/2018
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1972097103
Products in Payments
- IMBRUVICA (Drug) $338.81
- KISQALI (Drug) $271.16
- KEYTRUDA (Biological) $237.13
- LUMAKRAS (Drug) $201.89
- ELIQUIS (Drug) $192.67
- XPOVIO (Drug) $155.82
- XARELTO (Drug) $148.33
- MONJUVI (Drug) $130.04
- IMFINZI (Biological) $119.50
- OPDIVO (Biological) $118.39
- CALQUENCE (Drug) $114.63
- ZEPZELCA (Drug) $112.26
- LYNPARZA (Drug) $110.04
- PROMACTA (Drug) $107.18
- DARZALEX (Biological) $105.43
- PADCEV (Biological) $101.59
- MEKINIST (Drug) $79.16
- Kyprolis (Drug) $79.02
- BRUKINSA (Drug) $66.60
- Doptelet (Drug) $62.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Princeton
Tonya Krieg, Np, NP
Nurse Practitioner — Payments: $1,819
Vonetta Vories, Fnp-C, FNP-C
Nurse Practitioner — Payments: $1,674
Kevin Liebmann
Nurse Practitioner — Payments: $1,663
Stephanie Mundy, Aprn, APRN
Nurse Practitioner — Payments: $1,477
Christine Deluca, Np, NP
Nurse Practitioner — Payments: $1,257
Mellisa Hall, N.p, N.P
Nurse Practitioner — Payments: $1,040